Is Now the Time to Buy or Sell Silver?

NYSE: SLV | iShares Silver Trust News, Ratings, and Charts

SLV – After it’s recent reversal, is now the time to buy or sell silver? Analyzing options activity can give us some insight.

The story of the last month or so has been the rise in precious metals prices. Gold set record highs at more than $2,000 per ounce. And while not at record highs, silver was up over 60% for the year at one point. Whether talking about bullion, futures, or miners, pretty much any type of gold or silver investment was paying off big.

Then, on August 11, precious metals tanked. Gold futures dropped nearly 6% for the day, and silver got hit even harder. Silver futures plunged by almost 15% when all was said and done. After performing so well in previous weeks, the fall of silver must have come as a significant shock to investors.

None of this is to say that the precious metals run is over. It’s possible this is a brief correction on the road to even higher highs. Only time will tell when it comes to the longer-term performance of precious metals.

Is there anything we can glean from this recent action in silver? Should investors use this drop as a reason to exit the trade? Or, is the 15% decline in silver prices a reason to load up on the commodity at a discount?

One type of analysis you can do in this situation is based on options activity. That is, look at what’s going on in the options market to get some insight into what investors were thinking the day of the big drop.

iShares Silver Trust (SLV)

Looking at iShares Silver Trust (SLV) on the day of the drop, we can see a massive amount of options volume. Over 1.6 million options traded, which is four times the regular volume. Keep in mind, SLV is the most popular way for investors to gain exposure to silver.

The interesting thing is that despite the 14% drop in SLV (it fell slightly less than futures prices), most of the activity in SLV options was on the call side. When call action is extreme, it tends to be a bullish indicator. In this case, 73% of the activity was in calls. Think about it this way: an investor buys calls if they expect the underlying instrument to go up. However, even selling calls (especially out-of-the-money calls) is moderately bullish, such as a covered call trade.

One example of a straight-up bullish trade is an inter-market sweep of calls. That’s when the call buyer purchases every call available, across all exchanges, at a certain strike. In this case, a buyer purchased over 5,200 of the October 35 calls for 79 cents when SLV was around $25. The trader used an inter-market sweep and actually paid slightly more than the best ask price (77 cents) to do so. That’s certainly a bullish trade.

A lot can happen by October expiration, but buying more than 5,000 calls so far away from the current price definitely makes a statement. That’s not the type of trade that would typically be used as a hedge of a short position. In other words, it does seem to suggest the price of silver could be bouncing back in the next couple of months.

Want more great investing ideas?

Download free the “10-Step Options Trading Checklist” you need before making a trade.

The Virtual Trading Pit Is Open: Trade Set-ups, Training, New Trading Ideas

How to Try Out Options Without Risking a Penny


SLV shares were unchanged in after-hours trading Wednesday. Year-to-date, SLV has gained 40.41%, versus a 5.92% rise in the benchmark S&P 500 index during the same period.


About the Author: Jay Soloff


Jay is the lead Options Portfolio Manager at Investors Alley. He is the editor of Options Floor Trader PRO, an investment advisory bringing you professional options trading strategies. Jay was formerly a professional options market maker on the floor of the CBOE and has been trading options for over two decades. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
SLVGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


:  |  News, Ratings, and Charts

How to Beat the Market the Rest of the Year?

The easy gains that came at the start of this new bull market are fading away fast. In fact the stock market (SPY) has become quite volatile with gains harder to come by. Gladly there are solutions as will be shared in this commentary to get you on the right path to outperform the market through the end of 2021 and beyond. Read the rest below...

:  |  News, Ratings, and Charts

2022 Stock Market Outlook

The stock market (SPY) has continued on a bullish path in 2021. Will that continue in 2022? And what could happen to awaken the bear market from hibernation? 40 year investment veteran Steve Reitmeister explores this and more in this early edition of his 2022 Stock Market Outlook. Read on for full details below...

:  |  News, Ratings, and Charts

3 Cheap Healthcare Stocks to Buy Right Now

Healthcare stocks saw renewed interest due to the onset of the pandemic, but It’s not only COVID that is driving returns. The Baby Boomer generation is getting older, which is resulting in increased demand for healthcare products and services. That’s why investors should consider adding undervalued healthcare stocks such as Ironwood Pharmaceuticals, Inc. (IRWD), Nu Skin Enterprises, Inc. (NUS), and Bristol-Myers Squibb Co. (BMY) to their portfolio.

:  |  News, Ratings, and Charts

3 Value Stocks to Buy While You Still Can

After outperforming from last fall into the spring, value stocks have been overtaken by growth stocks, but that is expected to change as the economic recovery continues. So, now is the time to start putting your money to work in undervalued companies that offer the potential for strong returns such as Gilead Sciences Inc. (GILD), HP Inc. (HPQ), and CNH Industrial N.V. (CNHI).

:  |  News, Ratings, and Charts

3 Cheap Healthcare Stocks to Buy Right Now

Healthcare stocks saw renewed interest due to the onset of the pandemic, but It’s not only COVID that is driving returns. The Baby Boomer generation is getting older, which is resulting in increased demand for healthcare products and services. That’s why investors should consider adding undervalued healthcare stocks such as Ironwood Pharmaceuticals, Inc. (IRWD), Nu Skin Enterprises, Inc. (NUS), and Bristol-Myers Squibb Co. (BMY) to their portfolio.

Read More Stories

More iShares Silver Trust (SLV) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All SLV News